GMP Contracting, Inc.
"FDA strongly recommends that your management immediately undertake a comprehensive assessment of your operations, including facility design, procedures, personnel, processes, materials and systems. In particular, this review should assess your aseptic processing operations. A third party consultant with relevant sterile drug manufacturing expertise could be useful in conducting this comprehensive evaluation."
Standard statement used in FDA Warning Letters issued to Compounding Pharmacies.
Matt Bestercy (631) 838-9083 email@example.com